UBC Therapeutics Initiative

Dr. Juan Erviti is a qualified hospital pharmacist in Pamplona, Navarra, Spain. His research activity is focused on pharmacoepidemiology and systematic reviews, and has published over 50 articles in high impact medical journals. He is the Director of the Navarre Cochrane Associate Center and a member of the Cochrane Hypertension satellite group in Spain. He […]

Featuring Cases by: Shauna Archer, NP (F) Victoria BC – Case #1: “Can deprescribing ameliorate postural hypotension in a man with complex mental health issues?” Marc Clark MD, FCFP, Edmonton AB – Cases #2 and #3: “Back from the ‘pre-dead’ – hospice patients who bounced back after deprescribing” LEARNING OBJECTIVES: By the end of the […]

When challenged by complex cases involving people taking too many medications, we may ask: Can I stop any of these? Which should I stop first? Do I need to taper this drug? If so, how? What should I monitor for after stopping, and when? Many clinicians address these clinical questions successfully, improving outcomes for patients. […]

When challenged by complex cases involving people taking too many medications, we may ask: Can I stop any of these? Which should I stop first? Do I need to taper this drug? If so, how? What should I monitor for after stopping, and when? Many clinicians address these clinical questions successfully, improving outcomes for patients. […]

In this TI Best Evidence webinar, Dr. Mark Horowitz will present the Maudsley Deprescribing Guidelines approach to deprescribing antidepressants and share insights about distinguishing between the withdrawal effects resulting from stopping antidepressants and the relapse of underlying conditions. He will also describe the method of hyperbolic tapering to stopping antidepressants. There will be an opportunity for participants to ask questions. […]

When challenged by complex cases involving people taking too many medications, we may ask: Can I stop any of these? Which should I stop first? Do I need to taper this drug? If so, how? What should I monitor for after stopping, and when? Many clinicians address these clinical questions successfully, improving outcomes for patients. […]